Abstract:Vitamin B 12 deficiency is a major public health problem worldwide, with the highest burden in elderly people, pregnant women, and young children. Due to its role in DNA synthesis and methylation, folate metabolism, and erythropoiesis, vitamin B 12 supplementation during pregnancy may confer longer‐term benefits to maternal and child health outcomes. To evaluate the benefits and harms of oral vitamin B 12 supplementation during pregnancy on maternal and child health outcomes. We searched the Cochrane Pregnancy and Childbirth's Trials Register, ClinicalTrials.gov, the World Health Organization International Clinical Trials Registry Platform (ICTRP) on 2 June 2023, and reference lists of retrieved studies. Randomised controlled trials (RCTs), quasi‐RCTs, or cluster‐RCTs evaluating the effects of oral vitamin B 12 supplementation compared to placebo or no vitamin B 12 supplementation during pregnancy. We used standard Cochrane methods. Four review authors independently assessed trial eligibility. Two review authors independently extracted data from included studies and conducted checks for accuracy. Three review authors independently assessed the risk of bias of the included studies using the Cochrane RoB 1 tool. We used GRADE to evaluate the certainty of evidence for primary outcomes. The review included five trials with 984 pregnant women. All trials were conducted in low‐ and middle‐income countries, including India, Bangladesh, South Africa, and Croatia. At enrolment, 26% to 51% of pregnant women had vitamin B 12 deficiency (less than 150 pmol/L), and the prevalence of anaemia (haemoglobin less than 11.0 g/dL) ranged from 30% to 46%. The dosage of vitamin B 12 supplementation varied from 5 μg/day to 250 μg/day, with administration beginning at 8 to 28 weeks' gestation through to delivery or three months' postpartum, and the duration of supplementation ranged from 8 to 16 weeks to 32 to 38 weeks. Three trials, involving 609 pregnant women, contributed data for meta‐analyses of the effects of vitamin B 12 supplementation compared to placebo or no vitamin B 12 supplementation. Maternal anaemia: there may be little to no difference for maternal anaemia by intervention group, but the evidence is very uncertain (70.9% versus 65.0%; risk ratio (RR) 1.08, 95% confidence interval (CI) 0.93 to 1.26; 2 trials, 284 women; very low‐certainty evidence). Maternal vitamin B 12 status: vitamin B 12 supplementation during pregnancy may reduce the risk of maternal vitamin B 12 deficiency compared to placebo or no vitamin B 12 supplementation, but the evidence is very uncertain (25.9% versus 67.9%; RR 0.38, 95% CI 0.28 to 0.51; 2 trials, 272 women; very low‐certainty evidence). Women who received vitamin B 12 supplements during pregnancy may have higher total vitamin B 12 concentrations compared to placebo or no vitamin B 12 supplementation (mean difference (MD) 60.89 pmol/L, 95% CI 40.86 to 80.92; 3 trials, 412 women). However, there was substantial heterogeneity (I 2 = 85%). Adverse pregnancy outcomes: the evidence is uncertain about the effect on adverse pregnancy outcomes, including preterm birth (RR 0.97, 95% CI 0.55 to 1.74; 2 trials, 340 women; low‐certainty evidence), and low birthweight (RR 1.50, 95% CI 0.93 to 2.43; 2 trials, 344 women; low‐certainty evidence). Two trials reported data on spontaneous abortion (or miscarriage); however, the trials did not report quantitative data for meta‐analysis and there was no clear definition of spontaneous abortion in the study reports. No trials evaluated the effects of vitamin B 12 supplementation during pregnancy on neural tube defects. Infant vitamin B 12 status: children born to women who received vitamin B 12 supplementation had higher total vitamin B 12 concentrations compared to placebo or no vitamin B 12 supplementation (MD 71.89 pmol/L, 95% CI 20.23 to 123.54; 2 trials, 144 children). Child cognitive outcomes : three ancillary analyses of one trial reported child cognitive outcomes; however, data were not reported in a format that could be included in quantitative meta‐analyses. In one study, maternal vitamin B 12 supplementation did not improve neurodevelopment status (e.g. cognitive, language (receptive and expressive), motor (fine and gross), social‐emotional, or adaptive (conceptual, social, practical) domains) in children compared to placebo (9 months, Bayley Scales of Infant and Toddler Development Third Edition (BSID‐III); 1 trial; low‐certainty evidence) or neurophysiological outcomes (72 months, event‐related potential measures; 1 trial; low‐certainty evidence), though children born to women who received vitamin B 12 supplementatio -Abstract Truncated-

Association of Antenatal Vitamin B Complex Supplementation with Neonatal Vitamin B12status: Evidence from a Cluster Randomized Controlled Trial

Title: Effects of vitamin B complex supplementation during pregnancy on neonatal vitamin B 12 status: 1 evidence from a cluster randomized controlled trial

Association between Folic Acid and Vitamin B Complex Supplementation during Peri-conception Period and Neonatal ;Birth Weight

Vitamin B12 supplementation during pregnancy for maternal and child health outcomes

Maternal B-vitamin intake and B-vitamin supplementation during pregnancy in relation to neonatal congenital heart defects: a case-control study with propensity score matching

Micronutrient Supplementation and Pregnancy Outcomes: Double-Blind Randomized Controlled Trial in China.

Effects of maternal vitamin B12 supplementation on early infant neurocognitive outcomes: a randomized controlled clinical trial

Association of Antenatal Micronutrient Supplementation With Adolescent Intellectual Development in Rural Western China: 14-Year Follow-up From a Randomized Clinical Trial.

Effects of Dietary Intervention on Vitamin B12 Status and Cognitive Level of 18-Month-old Toddlers in High-Poverty Areas: a Cluster-Randomized Controlled Trial

Vitamin D status in women with dichorionic twin pregnancies and their neonates: a pilot study in China

Effects of maternal multimicronutrient supplementation on the mental development of infants in rural western China: follow-up evaluation of a double-blind, randomized, controlled trial.

Associations of B Vitamin-Related Dietary Pattern during Pregnancy with Birth Outcomes: A Population-Based Study in Northwest China

The effect of vitamin B12 supplementation during pregnancy on infant growth and development in Nepal: a community-based, double-blind, randomised, placebo-controlled trial

Prenatal Iron Supplementation Reduces Maternal Anemia, Iron Deficiency, And Iron Deficiency Anemia In A Randomized Clinical Trial In Rural China, But Iron Deficiency Remains Widespread In Mothers And Neonates

Impact of Micronutrient Supplementation During Pregnancy on Birth Weight, Duration of Gestation, and Perinatal Mortality in Rural Western China: Double Blind Cluster Randomised Controlled Trial (vol 337, A2001, 2008)

Prenatal Iron Containing Supplements Provided to Chinese Women with No or Mild Anemia Had No Effect on Hemoglobin Concentration in Post-Partum Women or Their Infants at 6 and 12 Months of Age

Maternal Serum Vitamin B12, Folate and Homocysteine and the Risk of Neural Tube Defects in the Offspring in a High-Risk Area of China

Adherence and costs of micronutrient supplementation in pregnancy in a double-blind, randomized, controlled trial in rural western China.

A micronutrient supplement during preconception and pregnancy increases human milk vitamin D but not B vitamin concentrations

Vitamin B_(12) Nutritional Status and Its Correlation with Diet in 18 Months Old Toddlers in Impoverished Area

The association between prenatal micronutrient supplementation and early development of children under age two: Evidence from rural Guizhou, China